Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:AALBF OTCMKTS:BVII OTCMKTS:DRWN OTCMKTS:RHHVF On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAALBFAalberts$47.00$41.52$30.30▼$47.00N/AN/A841 shs59 shsBVII(BVII)$0.00$0.03▼$0.10N/AN/A3,442 shsN/ADRWNA Clean Slate$0.00$0.00▼$0.00N/A0.241 shsN/ARHHVFRoche$391.47$406.39$300.15▼$490.33N/AN/A16,807 shs158 shs5G Stocks: The Path Forward is ProfitableClick the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAALBFAalberts0.00%+5.76%+10.12%+27.68%+31.14%DRWNA Clean Slate0.00%0.00%0.00%0.00%0.00%RHHVFRoche0.00%-6.47%-6.18%+2.26%+22.91%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAALBFAalberts$47.00$41.52$30.30▼$47.00N/AN/A841 shs59 shsBVII(BVII)$0.00$0.03▼$0.10N/AN/A3,442 shsN/ADRWNA Clean Slate$0.00$0.00▼$0.00N/A0.241 shsN/ARHHVFRoche$391.47$406.39$300.15▼$490.33N/AN/A16,807 shs158 shs5G Stocks: The Path Forward is ProfitableClick the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAALBFAalberts0.00%+5.76%+10.12%+27.68%+31.14%DRWNA Clean Slate0.00%0.00%0.00%0.00%0.00%RHHVFRoche0.00%-6.47%-6.18%+2.26%+22.91%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAALBFAalberts 3.00BuyN/AN/ABVII(BVII) 0.00N/AN/AN/ADRWNA Clean Slate 0.00N/AN/AN/ARHHVFRoche 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest RHHVF, BVII, DRWN, and AALBF Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/20/2026AALBFAalberts BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOverweight(Data available from 6/20/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAALBFAalbertsN/AN/AN/AN/AN/AN/ABVII(BVII)N/AN/AN/AN/AN/AN/ADRWNA Clean SlateN/AN/AN/AN/AN/AN/ARHHVFRocheN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAALBFAalbertsN/A$1.2737.09N/AN/AN/AN/AN/A7/23/2026 (Estimated)BVII(BVII)N/AN/AN/AN/AN/AN/AN/AN/AN/ADRWNA Clean SlateN/AN/AN/AN/AN/AN/AN/AN/AN/ARHHVFRocheN/A$10.8136.21N/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthAALBFAalberts$0.350.74%N/A27.50%N/ABVII(BVII)N/AN/AN/AN/AN/ADRWNA Clean SlateN/AN/AN/AN/AN/ARHHVFRoche$7.801.99%N/A72.16%N/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAALBFAalberts46.99%BVII(BVII)N/ADRWNA Clean SlateN/ARHHVFRoche29.01%Insider OwnershipCompanyInsider OwnershipAALBFAalbertsN/ABVII(BVII)N/ADRWNA Clean Slate19.10%RHHVFRocheN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAALBFAalberts14,055N/AN/ANot OptionableBVII(BVII)147,000N/AN/ANot OptionableDRWNA Clean Slate1N/AN/ANot OptionableRHHVFRoche103,605N/AN/ANot OptionableRHHVF, BVII, DRWN, and AALBF HeadlinesRecent News About These CompaniesFDA Accepts Roche's Filing for Lunsumio VELO-Polivy in LBCLJune 18 at 1:50 PM | zacks.comFDA approves first generic version of Roche's flu drugJune 17 at 6:35 PM | reuters.comJAZZ's Zepzelca Fails to Meet Primary Goal in Lung Cancer StudyJune 15, 2026 | zacks.comRoche's Tecentriq Plus Chemo Gets FDA Priority Tag for Colon CancerJune 11, 2026 | zacks.comPatent Cliff Predators: GSK Acquires Nuvalent For $10.6 Billion (RHHVF)...June 11, 2026 | marketbeat.comRoche sticks to German investment after Eli Lilly cutsJune 9, 2026 | reuters.comRoche (OTCMKTS:RHHVF) Stock Price Down 4.2% - Time to Sell?June 9, 2026 | americanbankingnews.comRoche Enters $2.3 Billion Blood-Cancer Drug Deal With Nurix TherapeuticsJune 8, 2026 | wsj.comRoche obesity drug helps patients shed 22.7% of weight in mid-stage trialJune 5, 2026 | reuters.comASCO 2026: A quiet conference for European pharma, but AstraZeneca and Roche both have work to doJune 1, 2026 | proactiveinvestors.co.ukRoche gets second European approval for Alzheimer's testMay 12, 2026 | reuters.comRoche to Buy PathAI for Up to $1.05 Billion to Bolster AI Diagnostics ToolsMay 7, 2026 | wsj.comSwitzerland's Roche agrees to acquire US-based PathAIMay 7, 2026 | reuters.comBarclays Reaffirms Their Buy Rating on Roche Holding AG (RHHVF)April 30, 2026 | theglobeandmail.comRoche Backs Full-Year View as Quarterly Sales RiseApril 23, 2026 | wsj.comRoche Q1 sales down on forex effectsApril 23, 2026 | reuters.comRoche submits multiple sclerosis drug fenebrutinib to regulators despite patient deathsApril 22, 2026 | reuters.comRoche launches new Elevidys study after feedback from European regulatorApril 16, 2026 | reuters.comC4 Therapeutics, Roche expand partnership with new cancer deal worth over $1 billionApril 9, 2026 | reuters.comHNL Lab Medicine Celebrates Preferred Partnership With Roche DiagnosticsApril 7, 2026 | globenewswire.comAnalysts Are Bullish on These Healthcare Stocks: IQVIA Holdings (IQV), Roche Holding AG (RHHVF)March 13, 2026 | theglobeandmail.comMedia Sentiment Over TimeRHHVF, BVII, DRWN, and AALBF Company DescriptionsAalberts OTCMKTS:AALBF$47.00 0.00 (0.00%) As of 06/18/2026Aalberts N.V. offers mission-critical technologies for aerospace, automotive, building, and maritime sectors. It operates through Building Technology and Industrial Technology sectors. The Building Technology segment develops, manufactures, and monitors hydronic flow control systems for heating and cooling to enhance the energy efficiency; and develops, designs, and manufactures integrated piping systems to distribute and regulate water or gas flows in heating, cooling, water, gas, and sprinkler systems in eco-friendly buildings and industrial niches. The Industrial Technology segment co-develops, engineers, and manufactures advanced mechatronics and technologies to regulate, measure, and control fluids under severe and critical conditions for active OEMs in semicon efficiency, sustainable transportation, and industrial niches; and offers a range of surface technologies utilizing a network of service locations local knowledge to customers active in sustainable transportation and industrial niches. It operates in Western Europe, the United States, Russia, Eastern Europe, the Asia-Pacific, the Middle East, and Africa. The company was formerly known as Aalberts Industries N.V. and changed its name to Aalberts N.V. in April 2019. Aalberts N.V. was founded in 1975 and is headquartered in Utrecht, the Netherlands.(BVII) OTCMKTS:BVIIBroadview Institute, Inc. is a career-focused post-secondary education services company. The Company operates primarily through its subsidiary, C Square Educational Enterprises, Inc. (Broadview University). Broadview University has campuses located in the Utah cities of Layton, Orem, Salt Lake City and West Jordan, as well as Boise, Idaho. Broadview University is accredited by the Accrediting Council for Independent Colleges and Schools (ACICS) to award diplomas, undergraduate degrees, and master's degrees in various fields of study. The Company's admissions department interviews potential applicants, provides information regarding its academic programs, and assists with the overall application process. The Company helps its students to complete their program of study through admissions screening, financial planning and student services. The Company's classes are offered in the day and evening, and many courses are available through online delivery. It also provides assistance.A Clean Slate OTCMKTS:DRWNQuantum Medical Transport, Inc., doing business as Quantum Medical Data Services, operates as a medical blockchain data services company. It is developing a medical blockchain technology for secure data storage and data transfer. The company was formerly known as A Clean Slate, Inc. and changed its name to Quantum Medical Transport, Inc. in August 2015. Quantum Medical Transport, Inc. is based in Sugar Land, Texas.Roche OTCMKTS:RHHVF$391.47 0.00 (0.00%) As of 06/18/2026 02:06 PM EasternRoche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/15 - 06/19 Satellogic Is Tiny But Its Revenue Growth Is Hard to Ignore Aehr Spikes on New Order, But Has Stock Gotten Ahead of Itself? Why Kroger’s Pullback Could Be a Gift for Patient Investors Credo Technologies Accelerates AI—Its Stock Price Will Follow Why Rocket Lab’s Nasdaq-100 Moment Could Change the Story Why Palantir’s Google Cloud Deal Could Change the Debate VMware: Broadcom's Second Biggest Business Set to Accelerate Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
